Post on 24-Sep-2020
Enhanced Recovery After Gynecological Surgery: Preoperative and Intraoperative Interventions
April Caalim RN-BSN, SRNAUnder the supervision of:
Ronald J. Piscotty, Jr. PhD, RN-BC, FAMIA, Ernestine Kaloko MS, CRNA
• Surgery induces major trauma to the body triggering a neuroendocrine and inflammatory stress response that impairs hemostasis.
• This can impede recovery and lead to complications such as post operative nausea and vomiting (PONV), development of venous thromboembolism, surgical site infection, and a diminished quality of life.
• Enhanced recovery after surgery (ERAS) programs help hasten recovery by minimizing the surgical stress response through evidence based interventions. Benefits include decreased hospital length of stay, costs, complications and increased patient satisfaction (Kalogera et. al., 2013; Modessit et. al, 2017).
• At a community hospital in the mid-Atlantic region, anesthesia providers are seeking for ways in which hospital length of stay and postoperative complications can be reduced in patients undergoing gynecological surgery.
Problem Results
Enhanced recovery after surgery clinical practice guidelines help improve the perioperative care of patients undergoing GYN surgery These interventions help decrease hospital length of stay, cost, and complications. Further, they help improve the well-being of patients and increase patient satisfaction. Due to the favorable results of the AGREE II Tool and PFQ surveys, it is evident that the developed CPG is of high quality and its use will be accepted at this institution.
Conclusions
The purpose of this Quality Improvement project was to create a Clinical Practice Guideline (CPG) for Enhanced Recovery after Gynecological Surgery with a focus on preoperative and intraoperative interventions.
Purpose
Bibliography
Setting: Community hospital in the mid-Atlantic regionPopulation: Utilization of the CPG is intended for the anesthesia providers of the institution pertaining to adult inpatient women undergoing GYN surgeryCPG Development: A literature review was conducted to determine the latest evidence-based interventions regarding ERAS for GYN surgery. Systematic reviews and meta-analyses, randomized controlled trials, retrospective cohort studies and published clinical practice guidelines were reviewed. The initial CPG draft was created and presented to the expert panel. Feedback from key stakeholders were incorporated into the CPG utilizing the AGREE II Tool. The final draft of the CPG was presented to the anesthesia providers of the institution. PFQ surveys were distributed to all in attendance and collected anonymously at the end of the presentation. Descriptive statistics was utilized to analyze the results of both surveys.
Methods
Discussion
With much appreciation to the support provided by Veronica Amos PhD, CRNA, PHCNS-BC, Clyde Pray MD, and friends and family.
Acknowledgements
• The results of the AGREE II Tool and PFQ surveys are indicative of the quality, usability, and wide acceptance of the CPG by the institution.
• The developed ERAS CPG was based on an extensive literature review and is in agreement with the current evidence.
• It is recommended that the ERAS CPG be adopted as a policy at the institution. To help ensure sustainability of the CPG, chart audits should be conducted by anesthesia staff, and the effectiveness of the interventions should also be communicated.
• Limitations of this QI project include limited generalizability to other institutions. This CPG was developed in close conjunction with stakeholders and are specifically tailored to this community hospital.
Kalogera, E., Bakkum-Gamez, J. N., Jankowski, C. J., Trabuco, E., Lovely, J. K., Dhanorker, S., … Dowdy, S. C. (2013). Enhanced recovery in gynecologic gurgery. Obstetrics and Gynecology, 122(2 0 1), 319–328. https://doi.org/10.1097/AOG.0b013e31829aa780
Modesitt, S. C., Sarosiek, B. M., Trowbridge, E. R., Redick, D. L., Shah, P. M., Thiele, R. H., . . . Hedrick, T. L. (2017). Enhanced Recovery Implementation in Major Gynecologic Surgeries. Obstetrical & Gynecological Survey,72(1), 19-21. doi:10.1097/01.ogx.0000511085.61752.f2
AGREE II TOOL Score (%)
Scope and Purpose 97.2Stakeholder Involvement 100
Rigour of Development 87.5
Clarity of Presentation 93Applicability 91.7
Editorial Independence 89.6Overall domain score 92
100 95.5
78.3
96.7 100
4.3
21.7
3.3 00 0 0 0 00
20
40
60
80
100
120
Quality Acceptance ofRecommendations
Applicability ofRecommendations
Comparative Value Outcome Variables
% A
GREE
MEN
T PRACTITIONER FEEDBACK QUESTIONNAIRE
Strongly Agree Neither agree nor disagree Strongly Disagree
• The results of the AGREE II tool were favorable with a calculated total domain score of 92% indicating that the CPG is of high quality.
• The return rate for the PFQ surveys was 100% (n=15). The PFQ survey results revealed that 100% of providers believed that there is a need for an ERAS CPG, that its utilization will benefit patients, and that the draft guideline recommendations will be supported by the anesthesia providers of the institution.
Implementing an Evidence-based Tobacco CessationProtocol in an Adult Behavioral Health Unit
Ozioma Erondu BSN, RN Katherine Fornili DNP, MPH, RN, CARN, FIAAN
• Tobacco use is a common problem among adult behavioral health (BH) patients and is a major cause of avoidable morbidity and mortality;
• Over 480,000 deaths per year attributable to tobacco use; • 50% to 70% greater chance of dying from stroke or
coronary artery disease;• 85% chance of dying from lung, trachea, or bronchial
related cancer than non-smokers; • Lack of a structured tobacco cessation plan with
post-discharge continuation of nicotine replacement therapy (NRT) at a small rural community hospital in the Mid-Atlantic region of the U.S.
Background
Purpose: to reduce smoking-related risks by implementing and evaluating an evidence-based tobacco cessation protocol for adult patients (18 years or older) in an inpatient behavioral health unit (BHU)Short-Term Goals: By Week 8, at least 80% of identified tobacco-using patients will have:• An assessment of their level of nicotine dependence and
readiness-to-change tobacco use behaviors• Documentation of tobacco cessation brief counseling• Received nicotine replacement therapy (NRT) at discharge based
on their level of nicotine dependence• Received a coaching referral to the state’s Quitline Long-Term Goal: To increase the number of behavioral health (BH) patients who receive tobacco cessation interventions and decrease or quit their tobacco use
Objectives
Evidence Synthesis Table Results
• Similar rates of NRT prescribing at discharge for both baseline (46%) and implementation groups (47%)
• Further evaluation is needed to determine possible reason(s) for lack of significant increase in NRT prescribing.
• Possible contributing factors may include client levels of distress during intake assessment, eagerness to leave at time of discharge, offering NRT to patients that were not ready to change, and provider time constraints.
• Some provider resistance to utilizing the FTND (for level of dependence) and the RR (for level of readiness) to inform NRT dosing recommendations (Figure 3).
• Recommend further assessment of reasons for resistance, and reinforcement of strategies to improve provider buy-in and adherence to protocols.
• Patients with low levels of dependence (per FTND scores) may not need NRT; however, the providers felt comfortable prescribing NRT without FTND results.
• Quitline referrals may not be acceptable to or suitable for inpatient BHU patients with serious psychiatric disorders. Only one patient showed interest and agreed to be referred to the Quitline.
• Patients were provided the FTND and RR at admission for self-administration and were not re-approached before discharge. Patients may benefit from provider-administered FTND and RR following stabilization and closer to time of discharge.
• This project did not attempt to correlate levels of psychiatric problem severity to frequency of NRT prescribing.
Discussion & Limitations
• Search: “tobacco cessation in mental health”, “tobacco cessation protocol and mental health” (5 studies)
• Search Platform: OneSearch from the University of Maryland Health Science and Human Services Library
• Appraisal of level & quality of evidence: Johns Hopkins Nursing Evidence-based Practice Rating Scale (Newhouse, et al., 2006)
• Project Development: Seven Steps of Evidence-based Practice Model (Melnyk & Fineout-Overholt, 2011)
• Project Implementation: Mobilize, Assess, Plan, Implement and Track (MAP-IT) Framework (HealthyPeople.gov)
Search Strategy/Evidence Appraisal
Instruments, Provider Adherence & Receipt of NRT
Baseline Phase (3 weeks Pre-Implementation): (N=40)• 65% were current tobacco users; • 46% of tobacco users accepted NRT at discharge.
Implementation Phase: 8 weeks (N=170)• 53% were tobacco users (n=90). • 82% received brief counseling. Goal MET. • 33% completed FTND; 29% completed the RR.
Goals NOT MET.• 47% accepted NRT at discharge, although 100% were
offered NRT. Goal NOT MET. • Only 1 patient (1%) agreed to Quitline referral. Goal NOT MET.• There was no statistically significant relationship between higher
levels of dependence and higher levels of readiness X2 (1, N = 26) = 0.02, p = .9
• There was no statistically significant relationship between higher levels of dependence and receipt of NRT X2 (1, N = 30) = 1.09, p = .3
• There was no statistically significant relationship (alpha = 0.05) between higher levels of readiness and receipt of NRTX2 (1, N = 26) = 1.53, p = .2
Figure 4: Provider and Patient adherence with Interventions
• Fagerstrom Test for Nicotine Dependence (FTND) – Figure 1to assess each patient on admission for level of dependence
• Readiness Ruler (RR) to assess level of readiness to change (quit or cut down) – Figure 2
• Continuation of nicotine replacement therapy (NRT) and Quitline Referral (QR) offered by prescribing provider at discharge – Figure 3
• Tobacco cessation intervention checklist: Project-developed audit form to capture patient FTND, RR, NRT & QR data
• Weekly collection and analysis of checklist form data
Methods/Procedures
Figure 1: Fagerstrom Test for Nicotine Dependence (National Drug Research Institute, 2019)
AUTHOR/YEAR PURPOSE RESULTS
EVIDENCE LEVEL/QUALITY
Metse, et al., 2017
To assess efficacy of universal smoking cessation intervention in acute psychiatric inpatient setting, and continued reduction in smoking/quit behaviors post discharge
▼ Cigarettes smoked per day by 50%: Intervention group 58.2%; Control group 36.8% (p<.001)▲Quit attempts: Intervention group 65.4%; Control group 45.8% (p<.001)▲ Abstinence at 6 months: Intervention group 15%; Control Group 9.3% (p=.04)
II (RCT)A (High Quality)
Morris, et al., 2011
To evaluate effectiveness of community-based tobacco cessation interventions compared to Quitline only, for persons with mental illness
▼ Cigarettes smoked per day by 50%: Quitline plus community group 21%; Quitline only group 8% (p=0.0451)
II (RCT)A (High Quality)
Prochaska et al., 2014
To evaluate the efficacy of motivational tobacco cessation treatment plus NRT, compared to NRT only, on adult psychiatric inpatient smokers
▲ Abstinence at 6 months and 12 months: Intervention group 14.4% and 19.4%; Control group 6.5% and 10.9% respectively (p= .018)
II (RCT)B (Good Quality)
Rogers et al., 2016
To evaluate the effectiveness of a specialized telephone smoking-cessation intervention developed for BH patients compared to state Quitline.
▲Abstinence at 30 days: Intervention group than control group (26% vs 18%, OR=1.62, 95% CI= 1.24, 2.11)
II (RCT)A (High Quality)
Schuck et al., 2016)
To evaluate NRT use posthospitalization among adult inpatient BH tobacco users with use of transtheoretical-model tailored computer intervention, brief-on-unit counseling, optional 6-month NRT and 10-sessions cognitive behavioral cessation counseling.
▲ Likelihood for NRT request at discharge with higher levels of readiness (p< .01).▲24hr-quit attempt and self-report abstinence with NRT request and at 1-week follow-up 54% vs 25% (p<.05) and 14% vs 4% (p<.05) respectively.
II (RCT)B (Good Quality)
Figure 3: Readiness Ruler (MDQuit, 2019)
Figure 2: Nicotine Replacement Therapy recommendations (National Drug Research Institute, 2019)
Centers for Disease Control and Prevention (2018). Smoking and tobacco use: Current cigarette smoking amongadults in the United States. U.S. Department of Health & Human Services. Retrieved from https://www.cdc.gov/tobacco/data_statistics/fact_sheets/adult_data/cig_smoking/index.htm
Metse, A. P., Wiggers, J., Wye, P., Wolfenden, L., Freund, M., Clancy,R., … Bowman, J. A. (2017). Efficacy of a universal smoking cessation intervention initiated in inpatient psychiatry and continued post-discharge: A randomized controlled trial. The Australian and New Zealand Journal of Psychiatry, 51(4), 366–381. doi: 0.1177/0004867417692424
Prochaska, J. J., Hall, S. E., Delucchi, K., & Hall, S. M. (2014). Efficacy of initiating tobacco dependence treatmentin inpatient psychiatry: A randomized control trial. American Journal of Public Health, 104(8), 1557-1565. doi: 10.2105/AJPH.2013.301403
References
46.2%
82.2%
33.3%28.9%
46.7%
1.1%0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
Counseling Fagerstrom Readiness Ruler Received NRT Quitline
PERC
ENTA
GE
OF
PATI
ENTS
Adherence to Tobacco Cessation Protocols
Baseline Implementation
Contact Information: Ozioma Erondu: ozerondu@umaryland.eduKatherine Fornili- fornili@umaryland.edu
• Problem: in Maryland, women on Medicaid only receive dental benefits
while pregnant
• Utilization: 26.1% in 2016
• WIC sees up to 300 women monthly
• Dental Clinic unaware of women
• Dental care is safe during pregnancy
• Poor oral health during pregnancy causes:
• Preterm labor
• Early childhood caries
• Low birth weight
Background
• To implement a screening and referral process for dental disease in
pregnant women at WIC using the Maternal Oral Screening Tool
• 100% of staff at WIC location will be educated on dental care during
pregnancy and implementation plan by September 6th, 2019
• By December 2019, at least 80 referrals will be sent to the dental clinic.
Purpose & Goals
Discussion
Conclusions
• Quality Improvement Project
• Maternal Oral Screening Tool: validated tool
• IRB Approvals:
• University of Maryland, Baltimore
• Maryland Department of Health
• Implementation of a screening and referral process at WIC
• Women screened at WIC, referred to Dental Clinic
• Forms sent via email; dental clinical provided follow-up
• Weekly updates and data collection
Methods
Results
• Annual Oral Health Legislative Report. (2017). Maryland Department of Health. [Data file]. Retrieved from https://phpa.health.maryland.gov/oralhealth/Documents/2017LegislativeReport.pdf
• Battani, K., Casper, J., Costello, S., McClure, G., Straub, O., Welby, J.,…Tinanoff, N. (2018). Oral health care during pregnancy: practice guidelines for Maryland’s prenatal and dental providers. Baltimore, MD: Maryland Department of Health, Office of Oral Health. Retrieved from www.oralhealth4betterhealth.com
• Dental Plans. (2019). Maryland Health Connection. Retrieved from https://www.marylandhealthconnection.gov/shop-and-compare/dental-plans/
• George, A., Dahlen, H., Blinkhorn, A., Ajwani, S., Bhole, S., Ellis, S.,…Johnson, M. (2016). Measuring oral health during pregnancy: sensitivity and specificity of a maternal oral screening (MOS) tool. BMC Pregnancy Childbirth, 16, 347.
References
• 23% of all women seen at WIC had referrals sent to dental clinic
• 25% of women referred scheduled appointments at dental clinic
• 87% of women screened were positive for needing a referral
Dental Disease in Pregnant Women:
A Screening and Referral Process
Cara Greely, BS, RN & Karen Scheu, DNP, FNP-BC
Median
Goal
0
10
20
30
40
50
60
70
80
90
100
1 2 3 4 5 6
Perc
enta
ge o
f Wom
en R
efer
red
to D
enta
l Clin
ic
Bi-Weekly Observations
Pregnant Women Referred from Total Number Seen
0
10
20
30
40
50
60
70
80
90
100
1 2 3 4 5 6
Perc
enta
ge o
f Wom
en w
ho m
ade
Appo
intm
ent a
t th
e D
enta
l Clin
ic
Bi-Weekly Observations
Dental Clinic Appointments
Values
Goal
MedianGoal
0
10
20
30
40
50
60
70
80
90
100
1 2 3 4 5 6Perc
enta
ge o
f Wom
en R
efer
red
to D
enta
l Clin
ic
Bi-Weekly Observations
Pregnant Women Referred from Total Number Screened
• Interdisciplinary collaboration is necessary to identify women at risk for dental disease
and offer intervention while pregnant to utilize Medicaid benefit
• Most women screening positive indicating a need for care
• Recommend embedding screening/referral tool in electronic medical system
• Less screening and referrals than goal
• Likely barriers:
• Low health literacy
• Lack of time
• Disclosure Statement
• Communication increased between WIC and dental clinic
• Facilitators:
• Close geographic location of WIC and dental clinic
• Flexible staff
• Complex surgical procedures are increasingly being performed on an outpatient basis
• Emphasis placed on enhanced recovery and fast-tracking patients for discharge
• Evidence supports care standardization at discharge • Positive affect patient safety, patient satisfaction, and
institution efficiency• Decrease overall cost to the institution, readmission
rates, and length of stay
Problem Statement
• To implement a standardized discharge bundle (SDB) for patients undergoing vaginal or robotic hysterectomy procedures, as part of (ERAS) initiative
• Support nursing staff during the transition to a same-day discharge model
Project Purpose and Goals
Methods
Discussion
• This SDB was successfully piloted in several units, providing valuable benchmark data and demonstrating the feasibility of the bundle and use by nursing staff for potential future projects.
• Staff reported improvements in both knowledge and confidence scores in caring for and discharging this patient population.
Conclusions
Carter-Brooks, C., Du, A., Ruppert, K., Romanova, A., & Zyczynski, H. (2018). Implementation of a urogynecology-specific enhanced recovery after surgery (ERAS) pathway. American Journal of Obstetrics & Gynecology, 219(5):495.e1-495.e10. doi: 10.1016/j.ajog.2018.06.009
Modesitt, S., Sarosiek, B., Trowbridge, E., Redick, R., Shah, P., Thiele, R., …& Hendrick, T. (2016) Enhanced recovery implementation in major gynecologic surgeries: Effect of care standardization. Obstetrics & Gynecology, 128(3) 457-466. Doi: 10.1097/AOG.0000000000001555
References
Results
Setting: Post-Anesthesia Care Unit (PACU), Short Stay Unit (SSU), and General Surgical Unit (GSU) Population: Adult female surgical patients undergoing vaginal or robotic hysterectomy procedures by one medical group. Implementation: Twelve Weeks: October -December 2019• A GAP analysis for knowledge and confidence of nurses
pre/post implementation• Staff education on SDB components (personalized patient
education packet, list of discharge criteria, SMART Phrase discharge note, patient point of contact information)
• A SMART phrase discharge note documented by nursing staff to ensure all required discharge criteria was met
Implementation of a Standardized Discharge Bundle: An Enhanced Recovery After Surgery Initiative
Heather Johnson, BSN, RN;Bridgitte Gourley, DNP, CRNP
• Staff education on SDB components was provided to 87 nursing staff members on the included units, including 100% of the SSU staff.
• 26 patients met project inclusion criteria with approximately 73% meeting criteria for a same-day discharge using the SDB, no patients experienced same-day discharge.
• 42% of patients had the ERAS discharge SMART phrase note documented in their EMR
• Post-implementation gap analysis indicated score improvement in all areas regarding staff’s knowledge and confidence in caring and discharging this patient population.
Figure 2: Pre- and Post-Implementation Gap Analysis
Figure 1: Patients Eligible for SDD per SDB
• Short term education goals achieved:• Nursing staff reported feeling “more comfortable and
prepared” in caring and discharging this patient population, reflected in the GAP analysis.
• Medical staff reported a “positive change in current culture” surrounding the ERAS initiative with widespread acceptance of patients moving to a SDD model by the nursing staff
• Use of ERAS discharge SMART phrase by staff already familiar with discharging this patient population as “extended recovery” increases current workload, impacting rates of compliance.
Limitations• Unexpected departure of the medical staff project lead from
organization prior to project implementation.• All patients remained “extended recoveries” and did not
transfer to the SSU for SDD
Long Term Goals: By July 1, 2020:•75% of vaginal or robotic hysterectomy surgical patients •will have a SDD,75% of patients will have the ERAS discharge SMART phrase note documented in their EMR
A special thanks to Bridgitte Gourley, DNP, CRNP, Dr. Briana Walton, Johanna Devine, MSN, CRNP, Sue Lee, BSN, RN, Crystal Crider, BSN, RN, Jennifer King, MSN, RN, and Nathan Benefiel, BSN, RN. It was with your collective help, guidance, and support that this project was possible.
Short Term Goals: By December 31, 2019:• 100% of Short Stay Unit Registered Nurse (RN)s
educated on the SDB, ERAS initiative, and discharge criteria
• 50% of patients will have a same day discharge (SDD)
• 50% will have the ERAS discharge SMART phrase n• Post-Implementation Gap Analysis of Nursing Staff
knowledge and confidence improved
Implementing Behavioral Screening Protocols to Reduce Violence in the Emergency Department
William Mangana, BSN, RNElaine Bundy, DNP, CRNP,FNP-C
• Opioid crisis and lack of mental health resources are leading causes of increased violence in the emergency department (ED)
• Increase in violence led to increase in restraint orders, ≥ 100 per month in last 90 days
• Restraint orders are not Evidence Based Practice (EBP) for violent behavior in the ED
• Patients admitted to Emergency Department (ED) will complete the Modified DASA-IV self-evaluation tool
• Nurses that work in the ED will complete the Violence Assessment Tool when the threshold is met
• Nurses working in the Emergency Department will implement a Behavioral Assessment Protocol in order to reduce the number of violent episodes by 100%
Purpose Results/Figures Discussion
Conclusion
• Participants: All Patients being admitted to the ED inclined to/capable of completing the Modified DASA at a community hospital
• Based on EBP a Behavioral Assessment Protocol combining patient and caregiver was implemented using:
• modified Dynamic Appraisal Situational Aggression (DASA) survey • Given to every ED patient to self-identify potential
aggressive behavior
• Violence Assessment Tool (VAT)• Completed by nurse for all patients scoring 3 or more on
DASA• Combined score >4 and <6 equates to moderate risk, use
of techniques like moving to quiet rooms, low lighting• Combined score > 7 requires patient to be isolated,
referred to behavioral health
• Education was provided for Champions and Staff on both tools
• Quality Improvement Project
• Analysis by percent change pre- and post- implementation
Methods
Reference
Problem statement - An increase in violence and aggressive behavior in patients has led to an increase in violent incidents and subsequent increase in restraint orders
A two-tail t-test revealed a difference in the sample means (26.3 -9.4) pre and post the Behavioral Assessment Protocol implementation (p <0.05)
Patients with combined score between 4 and 6 (green) vs number exhibiting violent behavior, needing restraints following intervention (blue)
Patients with combined score above 7 (green) vs number exhibiting violent behavior, needing restraints following intervention (blue)
• Dickens, G. L., O’Shea, L. E., & Christensen, M. (2019, June 20). Structured assessments for imminent aggression in mental health and correctional settings: Systematic review and meta-analysis. International Journal of Nursing Studies, 104, 1-16. https://doi.org/https://doi.org/10.1016/j.ijnurstu.2020.103526
• Pich, J. V., Kable, A., & Hazelton, M. (2017, May 20). Antecedents and precipitants of patient-related violence in the emergency department: Results from the Australian VENT Study (Violence in Emergency Nursing and Triage). Australasian Emergency Nursing Journal, 20(), 107 - 113. http://dx.doi.org/10.1016/j.aenj.2017.05.005
• Rosenfeld, B., Foellmi, M., Khadivi, A., Wijetunga, C., Howe, J., Nijdam-Jones, A., ... Rotter, M. (2017). Determining When to Conduct a Violence Risk Assessment: Development and Initial Validation of the Fordham Risk Screening Tool (FRST). Law and Human Behavior, 41(4), 325 - 332. http://dx.doi.org/10.1037/lhb0000247
• The Behavioral Assessment Protocol can be used to assess potential violent behavior in order to decrease the likelihood of an incident thereby decreasing restraint orders. Restraint orders reduced from 27.5% to 1.5%
• Two-tail t-test: • Observed difference between sample means (26.3 – 9.4) is
convincing enough to conclude the protocol implemented was successful with a p-value < .05
• ED averaged > 100 restraint orders per month during 3 months prior to implementation, goal was to reduce to zero, reduced to 14 restraint orders in the last month of the project
• Expected 100% of ED RN’s to complete the VAT, the compliance rate was 95%
• Expected patient compliance of 100%, 98% of patients admitted were completing the modified DASA
• Future QI Projects:• Replication of Project across departments such as ICU and
Behavioral Health
• Education: • How to implement the Behavioral Assessment protocol • Proper Intervention Techniques for when intervention is needed
• Ongoing Success:• add a flag to the electronic medical record to alert RN’s completion
of VAT is required• Add DASA to intake paperwork permanently
t-Test: Two-Sample Assuming Equal Variances
Number of Restraint Orders per week before Implementation
Number of Restraint Orders per during Project Implementation
Mean 26.33 9.44Variance 12.50 41.78Observations 9.00 9.00Pooled Variance 27.14
Hypothesized Mean Difference 0.00df 16.00t Stat 6.88P(T<=t) one-tail 0.00t Critical one-tail 1.75P(T<=t) two-tail 0.00t Critical two-tail 2.12
Certified Registered Nurse Anesthetists (CRNAs) are educated and trained to provide:
Anesthesia• CRNAs provide approximately 45 million high-quality
& cost-effective anesthetics every year• CRNAs have been providing anesthesia for over 150
years • CRNAs are sole anesthesia providers in some rural
hospitals Acute, chronic, and interventional pain management
services• CRNAs practice multimodal pain management
• i.e. using nerve blocks for pain controlOrders for medications
• CRNAs write orders for preoperative, intraoperative & postoperative medications for surgical patients
ProblemCurrent law in Maryland does not grant CRNAs prescriptive authority
Background
Develop and evaluate an evidence-based health policy toolkit to be utilized as a resource to support legislation to grant CRNAs in Maryland prescriptive authority
Short time objectives: • CRNA approval of toolkit
Long time Objectives: • Approval of toolkit by Maryland Association of Nurse
Anesthetists (MANA).• Utilization of toolkit by CRNAs/ Student Registered
Nurse Anesthetists (SRNAs) at legislative meetings with policymakers
• Petition policymakers in the Maryland general assembly to introduce legislation supporting prescriptive authority for CRNAs
• Improve access to care (rural areas)• Assist with combating the opioid epidemic (multi-modal
pain management)
Objectives
Methods/ Implementation Strategies
Policy Toolkit Evaluation Results
The topic of prescriptive authority is of great interest among CRNAs in Maryland.
• 57.1% strongly agreed and 28.6% agreed CRNAs should have prescriptive authority and that the lack of prescriptive authority is a hinderance to the CRNA profession.
• 71.4% strongly agreed and 14.3% agreed CRNAs having prescriptive authority would improve patient outcomes.
• 71.4% strongly agreed and 28.6% agreed the toolkit is needed and would be supported by CRNAs in Maryland.
Cost effective analysis supports independently practicing CRNAs
• Anesthesia costs reduced by 25% (Hogan et al., 2010)
Next steps:
• Engage CRNAs in politics and policy• Increase participation and interest in CRNAs gaining
prescriptive authority• Demonstrate how prescriptive authority can be a
steppingstone to gaining full practice authority
Conclusions
Strengths:• Strong CRNA support for toolkit• Literature review evidence shows the benefits of
having CRNAs function as independent providers
Limitations: • Small sample size (N= 30)• Population specific (CRNAs)• Low participation rate among CRNAs (30.4%)
Strengths and limitations
• History of the CRNA profession• Talking points• Sample personal story & elevator speech• Policy brief• Sample letters to policymakers• Table outlining state status on prescriptive authority
Components of Policy Toolkit
PopulationInclusion criteria
All practicing CRNAs in Maryland • CRNAs engaged at MANA conference 2019
Phase I• Evidenced based policy toolkit development• Survey development• Survey and Toolkit approved by policy expert
Phase II• oral presentation at MANA • Toolkit and survey emailed to participants
Phase III• Data collection via SurveyMonkey® • Analysis via Excel®• Dissemination of results (MANA conference 2020, poster presentation at University
of Maryland School of Nursing)
Evidence-Based Policy Toolkit Supporting Prescriptive Authority for Maryland Nurse
AnesthetistsMyra Njapau-Dove, BSN, SRNA
University of Maryland School of NursingUnder Supervision of Veronica Amos PhD, CRNA, PHCNS-BC
Project Director Brittney Taylor DNP, CRNA
0.0%
10.0%
20.0%
30.0%
40.0%
50.0%
60.0%
70.0%
80.0%
StronglyDisagree
Disagree NeitherDisagree nor
Agree
Agree Strongly Agree
Policy Toolkit Evaluation
Need for Prescriptive AuthorityHaving prescriptive authority will improve patient outcomesPurpose of toolkit is informative and clearPolicy brief contains active and useful informationPersonal Story is persuasive and impactfulTable showing states with prescriptive authority is usefulThe need for the toolkit is evident
ReferencesAmerican Association of Nurse Anesthetists (AANA). (2018). Certified registered nurse anesthetist fact sheet. Retrieved from https://www.aana.com/membership/become-a-crna/crna-fact-sheet
Ghertner, R. & Groves, L. (2018). The Opioid Crisis and Economic Opportunity: Geographic and Economic Trends. ASPE Research Brief: U.S. Department of Health and Human Services. https://aspe.hhs.gov/system/files/pdf/259261/ASPEEconomicOpportunityOpioidCrisis.pdf
Hogan, P. F., Seifert, R. F., Moore, C. S., & Simonson, B. E. (2010). Cost-Effectiveness Analysis of anesthesia providers. Nursing Economics, 28(3), 159-169. Institute of Medicine. (2010, October). The future of nursing: Leading change, advancing health. Retrieved from https://iom.nationalacademies.org/~/media/Files/Report%20Files/2010/The-Future-Nursing/Future%20of%20Nursing%202010%20Report%20Brief.pdf
Background & Problem
Perioperative Anesthetic Antiobesity Medication Management: Clinical Practice Guideline
DeVontee’ D. Rayford, BSN, RN, Veronica Gutchell, DNP, RN, CNS, CRNP
Objectives
Methods
• 45% of the US population will be obese by 2030• Antiobesity medication use increased from 2.35 to 2.74 million between
2008 and 2011• There will be an increased number of surgical patients on antiobesity
medications• Antiobesity medications are not commonly encountered by anesthesia
providers leading to lack of knowledge and unique considerations• An anesthetic clinical practice guideline for antiobesity medications has
been developed to improve outcomes for patients undergoing surgical procedures requiring general and sedation anesthesia
• Purpose: The purpose of this doctoral project was the development of an evidenced based CPG at a local institution regarding the perioperative anesthetic management of FDA approved antiobesity medications.
• Short term goal: Development of an evidenced based CPG to increase the knowledge of anesthesia providers regarding the perioperative anesthetic management of antiobesity medications.
• Long tern goal: Adoption of the evidenced based CPG as institutional policy.
• Setting: Local community hospital servicing northwest Baltimore. • Population: This CPG will be utilized by anesthesia providers (CRNA,
MDA, SRNA)• Development Process:
• Phase 1: • Expert panel development: 2 DNP nurse anesthetists, an
anesthesiologist, and pharmacist• Expert panel meetings resulting in completion and interpretation of
AGREE II tool and final draft of CPG.• Phase 2:
• Approval of CPG by administrative stakeholders Chief CRNA , Chief and Vice-Chief Anesthesiologists
• Phase 3:• Presentation of CPG at an anesthesia grand rounds meeting to
providers and completion of PFQ.• Phase 4
• Presentation of AGREE II and PFQ data to expert panel and administrative members
• Final approval of finalzed CPG by all members
• Development of the evidenced based CPG accomplished overall project outcomes.
• Information from the CPG was utilized to update an existing policy regarding antiobesity medications for bariatric surgery patients.
• Major limitation: varying levels of evidenced utilized for CPG development secondary to minimal controlled studies.
• Evidence limitation lead to utilizing pharmacologic classes for development with no reduction is quality or applicability
• Results of CPG development addressed knowledge gap regarding perioperative antiobesity anesthetic management
• Evidence supports the utilization of an evidenced based guideline to benefit both patients and providers.
Discussion
Development & BibliographyStudy Relevant CPG Results
MacWalter et al., 2003; Rating: 6B
Design: Case study; n=1
Objectives: To report increased INR in patients on warfarin therapy after the addition of Orlistat.
Patient warfarin therapy consisted of alternating 5mg and 6 mg doses with a stable INR for greater than 1 year. Eighteen days after the initiation of Orlistat, patient INR increased to 4.7.
Dell’Orto et al., 2014; Rating: 1A
Design: Systemic Review; n=47
Objectives: To evaluate evidence associating topiramate with the development of metabolic acidosis, hypokalemia, and renal stone disease.
1) Significant trends in incidence of decreased bicarbonate levels by approximately 3-5 mmol and hyperchloremia. 2) Decreases in potassium of approximately 0.3 mmol.
Lim et al., 2018; Rating: 1B
Design: Systematic Review; n=4
Objective: To evaluate evidence supporting phentermine associated anesthetic risks, primarily refractory hypotension, and its management.
-Sympathomimetic with 20-hour half-life- MOA: MAO and Serotonin reuptake inhibition-Concurrent with MAO or serotonergic medication: serotonin toxicity, carcinoid syndrome-like valvular disease and pulmonary hypertension -Side effects: tachycardia, arrhythmias, CNS stimulation, hyperthermia-Refractory hypotension secondary to catecholamine depletion only responsive to direct acting vasopressors (phenylephrine)-Linked to hypertension crisis resembling pheochromocytoma-Recommendations: hold phentermine at least 4 days prior to surgery.
Smischney et al., 2018; Rating: 6B
Design: Case Report; n=1
Objective: report increased incidence of possibility of perioperative serotonin syndrome in patients taking antidepressants as evidence by a case report
Serotonin syndrome development secondary to administration of associated medications during an anesthetic: fentanyl, tramadol, meperidine, methadone, ondansetron, metoclopramide
Ninh et al., 2017; Rating: 6B
Design: Case Report; n=1
Objectives: To report difficulties in perioperative pain management in patients taking opioid antagonists as evidenced by a case report.
-Despite a multi-modal approach for pain control, the studied patient had inadequate pain control immediately postoperatively and up to post op day 2. -Recommendations: Hold Contrave for 7-10 days prior to opioid administration
Deane et al., 2010; Rating: 2A
Design: Randomized, double-blind, placebo-controlled crossover design
Objectives: To assess Glucagon-Like Peptide-1 (GLP-1) and its endogenous effects on gastric emptying and glucose.
1) Accelerated gastric emptying and shorter times to 50% gastric content reduction were noted along with gastric content reduction at 60 minutes (p<0.001). 2) 3-OMG levels did not change over time but had increased peak time (p<0.01) and higher 60-minute levels (p<0.05). 3) Increase noted in glucose response (p<0.05), peak glucose level (p<0.01), and 60 min blood glucose level (p<0.01). 4) Increased insulin levels noted at 60 minutes (p<0.05).
*All results are post administration of Exendin which is an GLP-1 antagonist
• Lorcaserin• Risk: Serotonin syndrome (SS) development• Interventions: Avoid SS related medications, monitor for signs and symptoms of
SS.• Naltrexone-bupropion
• Risk: Inadequate perioperative pain management • Interventions: multimodal pain management, regional anesthesia, hold for 4 days
preoperatively• Xenical
• Risk: Increased bleeding risk, supratherapeutic INR levels with concomitant chronic warfarin use
• Interventions: preoperative coagulation studies (INR, PTT, aPTT)• Phentermine-topiramate
• Risk: Hemodynamic alterations, refractory hypotension, metabolic acidosis, hypokalemia
• Interventions: Monitor and treat hemodynamic changes, treat refractory hypotension with direct acting agents, monitor electrolytes
• Liraglutide• Risk: Aspiration• Interventions: Consider rapid sequence induction and aspiration prophylaxis
CPG Recommendations
Results
0%10%20%30%40%50%60%70%80%90%
100%
Quality Acceptance Applicability ComparativeValue
OutcomeVariables
Subscales of Interest
PFQ Average Percentage Agreement
0%
20%
40%
60%
80%
100%
1 2 3 4 5 6Domain
AGREE II Tool Domain Percentages
Initial Revision
• The CPG serves as the basis addressing the knowledge gaps in perioperative antiobesity medication anesthetic management as supported by the literature.
• The CPG can be utilized to educate providers on common antiobesity medications and thus increasing awareness of the potential serious anesthetic implications.
Conclusion
• Adults with comorbidities such as asthma or diabetes mellitus are more susceptible to morbidity and mortality from vaccine-preventable illnesses, particularly pneumococcal disease.
• Data obtained between 2007-2010 from a population study found that adults aged 19-64 with diabetes have a significantly high risk of all-cause pneumonia than their healthy counterparts (IRR = 3.7 [95% CI 3.6-3.7]), with corresponding increase in healthcare costs.
• The CDC recommends a one-time pneumococcal polysaccharide (PPSV23) vaccination for these at-risk adults between the ages of 19-64.
• At this primary care clinic, a knowledge gap was identified where staff were only screening patients aged ≥65 years for PPSV23 vaccine need.
Problem Statement
• To implement a vaccine screening algorithm and patient education pamphlet as visual provider prompts in an effort to increase the proportion of adult patients with diabetes who receive the PPSV23 vaccination at a primary care clinic.
Short-term Goals:• At least 50% of patients eligible to receive the PPSV23 vaccine
will be identified by nursing staff or providers.• At least 75% of identified patients will obtain the PPSV23
vaccination prior to leaving the clinic.Long-term Goals:• All adult patients with diabetes who present for primary care
appointments will be screened for pneumococcal and hepatitis B vaccine needs.
• All adult patients with diabetes will obtain their PPSV23 vaccination within one year of diagnosis or identification of vaccine need
Purpose of the Project • Visual prompts and educational pamphlets can increase patient and provider awareness of adult vaccine needs.
• The findings in this project were comparable to other studies that found provider prompts increased vaccination rates, particularly for at- and high-risk adults.
• This project was conducted at a small primary care clinic and the results cannot be generalized to other settings.
Discussion
• This project supports the need for implementing provider prompts related to adult vaccination needs.
• Recommendation for integration of prompts within the EHR with drop-down options to improve workflow.
• Overlapping projects or multiple organizational changes in a short time-frame can negatively impact QI projects by spreading resources thin and provoking apathy among staff.
• Use of change champions are a critical component to influencing organizational culture for staff buy-in.
• Future projects at larger primary care practices would add validity to the results.
Conclusions
This project was implemented at a military primary care clinic in Maryland that sees Active Duty, dependent family members, and retirees across the lifespan.• Adult patients aged 19 – 64 years with a diagnosis of diabetes
without contraindication to the vaccine were included• The project was implemented over a 13 week timespan• Staff education and training on algorithm use• Screening algorithms were provided to all staff at the start of
the implementation period• Staff education related to anti-glycemic medications to improve
identification of adults with diabetes emailed at week 5, and patient education pamphlets placed in exam rooms at week 6
Methods
Figures
Centers for Disease Control and Prevention. (2020). Table 2. Recommended Adult Immunization Schedule by Medical Condition and Other Indications, United States. Retrieved from https://www.cdc.gov/vaccines/schedules/hcp/imz/adult-conditions.htmlGottlieb, R. P., & Dols, J. D. (2018). Improving Vaccination Rates in Adults With Type 2 Diabetes in a Family Practice Setting Through the Use of Evidence-Based Interventions. Journal of Doctoral Nursing Practice, 11(2), 151–159. doi: 10.1891/2380-9418.11.2.151Weycker, D., Farkouh, R. A., Strutton, D. R., Edelsberg, J., Shea, K. M., & Pelton, S. I. (2016). Rates and costs of invasive pneumococcal disease and pneumonia in persons with underlying medical conditions. BMC Health Services Research, 16(1). doi: 10.1186/s12913-016-1432-4
References
• A total of 170 eligible patients were seen during the implementation period, 48.23% were male (n=82) and 51.56% were female (n=88). Median age was 57 years.
• Weekly screening rates of eligible patients ranged from 10 – 86%. Vaccine need was identified for 41.76% of these patients (n=71). PPSV23 vaccines were obtained by 46.48% of identified, eligible patients (n=33).
• A Fisher’s exact test showed the intervention was effective at improving vaccination rates (p=.046), and a chi-square test for independence determined there was a relationship between screening the patient and the patient obtaining the PPSV23 vaccine (χ2= 57.10, p<.001)
Implementing a Pneumococcal Polysaccharide Vaccine Screening Tool for Adults with Diabetes
June Struder, BSN, RNHazel Jones-Parker, DNP, CRNP, AACRNUniversity of Maryland School of Nursing
Disclaimer: The views and information presented are those of the authors and do not represent the official position of the U.S. Army Medical Department Center and School Health Readiness Center of Excellence, the U.S. Army Training and Doctrine Command, or the Departments of Army, Department of Defense, or U.S. Government
Results
Figure 1. Weekly results of identifying eligible adults during pre- and implementation period
n = 11 5 2 12 10 13 10 15 11 20 14 13 10 24 7 11
Pre-implementation
Figure 2. Weekly rates of screening eligible patients for PPSV23 vaccine need
Background
Short Term GoalsImplement a structured post critical incident debriefing
process, using the TeamSTEPPS Debriefing Tool following 100% of high-risk deliveries in infants 22-32 week gestation and emergency/resuscitation codes in the NICU.Enhance positive team communication during debriefings.Long Term GoalAdoption and dissemination of the TeamSTEPPS Debriefing
Tool following 100% of emergency deliveries and critical events in the NICU.
Objectives Results
Formally training facilitators and educating staff in debriefing process increased post critical incident debriefsfrom 1% to 15% in the NICU.
Structured TeamSTEPPS tool lead to focused and positive communication during debriefings.
Similar to the literature, structured debriefingsdemonstrated improved team cohesiveness,communication, organization, role delineation, AND decreased patient stabilization time.
REFLECT evaluation tool indicated staff agreed the debriefings were focused, encouraged participation, andcommunication was effective.
Limitations: Large unit (n=239), high acuity, and limited time resulted in 20% of staff completing training and limited the number of structured debriefings (n=4, 15%) following critical events.
Conclusions
References
Collaborated with management of 52-bed, Level IV NICU in an academic medical center in the Mid-Atlantic region to implement structured TeamSTEPPS Debriefing Tool
Developed data collection tools to document QI project progress
Created/revised educational materials for multidisciplinary NICU staff
Trained champions/facilitators via in-person and online (to increase staff training) PowerPoints
Designed self learning binder to enhance training of NICU’s multidisciplinary staff
Exercised debriefing tool during code/delivery simulations to get staff accustomed to debriefing following code/delivery situations
Produced reminder cards to facilitate debriefing after 22-32 week deliveries and resuscitation/emergency events
Established plan to communicate debriefing findings with management and staff
Role modeled safe environment for structured debriefing
Implementation Methods
Figures
Let’s Talk: Post Critical Incident Debriefing ProjectTamara Wiseman, BSN, RN
Barbara Wise, PhD, RN, CPNP-AC/PCJennifer Fitzgerald, DNP, NNP-BC
University of Maryland School of Nursing
Structured debriefings after critical events rarely occur in a level IV Neonatal Intensive Care Unit (NICU)
Lack of structured debriefing Negatively impacts provider physical and emotional
health and patient outcomes Leads to unconstructive feedback and unidentified
areas for team and patient outcome improvement Clinical team debriefing sessions after a life-threatening
emergencies lead to improved: Team and individual learning opportunities Patient focused resuscitation outcomes Team communication
Standardized Debriefing tools Provide a structured method of debriefing Improve communication among team members Improve quality of patient safety and care
n=208%
n=16368%
n=18, 8%
n=31%
n=94%
n=83%
n=188%
NICU Staff (n=239)
RT RNNNP PAFellows ResidentsNeonatologists
n=2611% n=22
9%
n=19180%
NICU Staff Trained/Educated
Total Trained Champions/FacillitatorsTotal NICU Staff EducatedTotal NICU Staff Not Educated/Trained
Total NICU Staff= 239% Staff Trained/Educated= 20%
Total Debriefsn=415%
Total Did Not
Debriefn=2385%
Total 22-32 Week Deliveries and Emergency Resuscitation Codes
(n=27*)
Total DebriefsTotal Did Not…
* One debrief that occurred did not meet the inclusion criteria (36 weeks)
Discussion
7 completed toolsREFLECT Post
Debriefing Evaluation Tool
100% replied yes to all questions.
Implementation of a structured debriefing tool is feasible in a high acuity NICU.
Increased nursing and provider staff engagement, and ongoing training would enhance debriefing facilitation.
Large number of personnel and high patient acuity may have contributed to low number of debriefings.
Future considerations: Piloting in a smaller unit or level NICU Expanding to all emergent deliveries regardless of
gestational age Facilitating collaborative debriefs between OB and NICU
teams following maternal/neonatal emergencies
Agency for Healthcare Research & Quality. (2019). TeamStepps. Retrieved from https://www.ahrq.gov/teamstepps/index.htm
Agency for Healthcare Research & Quality. (2019). TeamStepps. Retrieved from https://www.ahrq.gov/teamstepps/instructor/fundamentals/module4/slleadership.html#im15
Cho, S. (2015). Debriefing in pediatrics. Korean Journal Of Pediatrics, 58(2), 47. doi: 10.3345/kjp.2015.58.2.47
Couper, K., Salman, B., Soar, J., Finn, J., & Perkins, G. (2013). Debriefing to improve outcomes from critical illness: a systematic review and meta-analysis. Intensive Care Medicine, 39(9), 1513-1523. doi: 10.1007/s00134-013-2951-7
Kessler, D., Cheng, A., & Mullan, P. (2015). Debriefing in the Emergency Department After Clinical Events: A Practical Guide. Annals Of Emergency Medicine, 65(6), 690-698. doi: 10.1016/j.annemergmed.2014.10.019
Thompson, R., Sullivan, S., Campbell, K., Osman, I., Statz, B., & Jung, H. (2018). Does a Written Tool to Guide Structured Debriefing Improve Discourse? Implications for Interprofessional Team Simulation. Journal Of Surgical Education. doi: 10.1016/j.jsurg.2018.07.001
Zinns, L., Mullan, P., OʼConnell, K., Ryan, L., & Wratney, A. (2017). An Evaluation of a New Debriefing Framework. Pediatric Emergency Care, 00(00), 1. doi: 10.1097/pec.0000000000001111
TeamSTEPPS Debriefing Tool Core Components
• Was communication clear throughout the event? (Closed loop communication, orders clearly understood, appropriate tone used amongst team members, etc.): Yes or No
• Were roles and responsibilities understood? Yes or No • Was the workload distribution clear? Was the team members present sufficient?
(Too many, too few, key personnel missing, etc.) Yes or No • Was situation awareness maintained? (Team members aware of their surroundings
and the needs of the NICU team during the critical incident) Yes or No • Did the team ask for or offer assistance? Yes or No • Were errors made or avoided, and/or any other issues? (Process, medication,
equipment, etc.) Yes or No • What went well? What did not go well? (Allow members to openly discuss team
problems or individual. *Respond using good judgment statements.) • What should change?